Literature DB >> 35583259

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease.

Caoilfhionn M Connolly1, Sarah Frey2, Teresa Po-Yu Chiang2, Mayan Teles2, Jennifer L Alejo2, Jemima Albayda1, Ami A Shah1, William A Werbel3, Dorry L Segev4, Lisa Christopher-Stine1, Julie J Paik1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35583259      PMCID： PMC9129174          DOI： 10.1093/rheumatology/keac298

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.046


× No keyword cloud information.
  8 in total

1.  A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients.

Authors:  Andrew H Karaba; Xianming Zhu; Tao Liang; Kristy H Wang; Alex G Rittenhouse; Olivia Akinde; Yolanda Eby; Jessica E Ruff; Joel N Blankson; Aura T Abedon; Jennifer L Alejo; Andrea L Cox; Justin R Bailey; Elizabeth A Thompson; Sabra L Klein; Daniel S Warren; Jacqueline M Garonzik-Wang; Brian J Boyarsky; Ioannis Sitaras; Andrew Pekosz; Dorry L Segev; Aaron A R Tobian; William A Werbel
Journal:  Am J Transplant       Date:  2022-01-18       Impact factor: 8.086

2.  Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.

Authors:  Francesca Romana Spinelli; Ennio Giulio Favalli; Fabrizio Conti; Roberto Caporali; Cristina Garufi; Martina Cornalba; Serena Colafrancesco
Journal:  Arthritis Res Ther       Date:  2022-01-11       Impact factor: 5.156

3.  Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.

Authors:  Sebastian Eduardo Sattui; Jean W Liew; Jonathan S Hausmann; Julia F Simard; Jeffrey A Sparks; Kevin Kennedy; Emily Sirotich; Michael Putman; Tarin T Moni; Akpabio Akpabio; Deshiré Alpízar-Rodríguez; Francis Berenbaum; Inita Bulina; Richard Conway; Aman Dev Singh; Eimear Duff; Karen L Durrant; Tamer A Gheita; Catherine L Hill; Richard A Howard; Bimba F Hoyer; Evelyn Hsieh; Lina El Kibbi; Adam Kilian; Alfred Hyoungju Kim; David F L Liew; Chieh Lo; Bruce Miller; Serena Mingolla; Michal Nudel; Candace A Palmerlee; Jasvinder A Singh; Namrata Singh; Manuel Francisco Ugarte-Gil; John Wallace; Kristen J Young; Suleman Bhana; Wendy Costello; Rebecca Grainger; Pedro M Machado; Philip C Robinson; Paul Sufka; Zachary S Wallace; Jinoos Yazdany; Carly Harrison; Maggie Larché; Mitchell Levine; Gary Foster; Lehana Thabane; Lisa G Rider
Journal:  RMD Open       Date:  2021-09

4.  Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.

Authors:  Jill M Ferdinands; Suchitra Rao; Brian E Dixon; Patrick K Mitchell; Malini B DeSilva; Stephanie A Irving; Ned Lewis; Karthik Natarajan; Edward Stenehjem; Shaun J Grannis; Jungmi Han; Charlene McEvoy; Toan C Ong; Allison L Naleway; Sarah E Reese; Peter J Embi; Kristin Dascomb; Nicola P Klein; Eric P Griggs; Deepika Konatham; Anupam B Kharbanda; Duck-Hye Yang; William F Fadel; Nancy Grisel; Kristin Goddard; Palak Patel; I-Chia Liao; Rebecca Birch; Nimish R Valvi; Sue Reynolds; Julie Arndorfer; Ousseny Zerbo; Monica Dickerson; Kempapura Murthy; Jeremiah Williams; Catherine H Bozio; Lenee Blanton; Jennifer R Verani; Stephanie J Schrag; Alexandra F Dalton; Mehiret H Wondimu; Ruth Link-Gelles; Eduardo Azziz-Baumgartner; Michelle A Barron; Manjusha Gaglani; Mark G Thompson; Bruce Fireman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-02-18       Impact factor: 17.586

5.  Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine.

Authors:  Rishi R Goel; Mark M Painter; Kendall A Lundgreen; Sokratis A Apostolidis; Amy E Baxter; Josephine R Giles; Divij Mathew; Ajinkya Pattekar; Arnold Reynaldi; David S Khoury; Sigrid Gouma; Philip Hicks; Sarah Dysinger; Amanda Hicks; Harsh Sharma; Sarah Herring; Scott Korte; Wumesh Kc; Derek A Oldridge; Rachel I Erickson; Madison E Weirick; Christopher M McAllister; Moses Awofolaju; Nicole Tanenbaum; Jeanette Dougherty; Sherea Long; Kurt D'Andrea; Jacob T Hamilton; Maura McLaughlin; Justine C Williams; Sharon Adamski; Oliva Kuthuru; Elizabeth M Drapeau; Miles P Davenport; Scott E Hensley; Paul Bates; Allison R Greenplate; E John Wherry
Journal:  Cell       Date:  2022-04-08       Impact factor: 66.850

6.  Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.

Authors:  Pedro M Machado; Saskia Lawson-Tovey; Anja Strangfeld; Elsa F Mateus; Kimme L Hyrich; Laure Gossec; Loreto Carmona; Ana Rodrigues; Bernd Raffeiner; Catia Duarte; Eric Hachulla; Eric Veillard; Eva Strakova; Gerd R Burmester; Gözde Kübra Yardımcı; Jose A Gomez-Puerta; Julija Zepa; Lianne Kearsley-Fleet; Ludovic Trefond; Maria Cunha; Marta Mosca; Martina Cornalba; Martin Soubrier; Nicolas Roux; Olivier Brocq; Patrick Durez; Richard Conway; Tiphaine Goulenok; Johannes Wj Bijlsma; Iain B McInnes; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2021-12-31       Impact factor: 19.103

7.  Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.

Authors:  Merav Heshin-Bekenstein; Amit Ziv; Natasa Toplak; David Hagin; Danielle Kadishevich; Yonatan A Butbul; Esther Saiag; Alla Kaufman; Gabi Shefer; Orli Sharon; Sara Pel; Ori Elkayam; Yosef Uziel
Journal:  Rheumatology (Oxford)       Date:  2022-02-18       Impact factor: 7.046

8.  Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.

Authors:  Caoilfhionn M Connolly; Jake A Ruddy; Brian J Boyarsky; Iulia Barbur; William A Werbel; Duvuru Geetha; Jacqueline M Garonzik-Wang; Dorry L Segev; Lisa Christopher-Stine; Julie J Paik
Journal:  Arthritis Rheumatol       Date:  2021-12-03       Impact factor: 10.995
  8 in total
  1 in total

1.  Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Authors:  Mayan S Teles; Caoilfhionn M Connolly; Rachel Wallwork; Sarah Frey; Teresa Po-Yu Chiang; Jennifer L Alejo; Jemima Albayda; Lisa Christopher-Stine; Dorry L Segev; William A Werbel; Julie J Paik
Journal:  Rheumatology (Oxford)       Date:  2022-06-27       Impact factor: 7.046
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.